期刊文献+

常规剂量与小剂量辛伐他汀伍用复方丹参滴丸的降脂疗效及毒副作用观察

Observation on the Therapeutic Effect and Side Effect of Conventional Dosage of Simvatatin and Lower Dosage of Simvatatin Combining with Danshen Dropping Pills
下载PDF
导出
摘要 目的 :探讨小剂量中西调脂药物合用的降脂疗效。方法 :冠心病合并高脂血症 10 4例 ,随机分为A、B两组 ,分别接受小剂量辛伐他汀 ( 5mg)伍用复方丹参滴丸与常规剂量辛伐他汀 ( 2 0mg)治疗 ,检测血浆中总胆固醇 (TC)、甘油三脂(TG)、低密度脂蛋白胆固醇 (LDL -C)、高密度脂蛋白胆固醇 (HDL -C)及脂蛋白小a(LP(a) )、谷氨酸氨基转移酶(ALT)、门冬氨酸转移酶 (AST)、肌酸磷酸激酶 (CK)治疗前后的变化。结果 :两组均能明显降低TC、TG、LDL -C ,增高HDL-C。A组降低TG更明显 ,并有降低LP(a)的作用 ;B组不能降低LP(a) ,A组毒副作用的发生率更低。结论 :小剂量辛伐他汀伍用复方丹参滴丸有全面的调脂作用 ,毒副作用少 ,更适合长期应用。 Objectives:To probe the therapeutic effect of the combining Traditional Chinese Medicine and Sinvatatin that can decrease the lipid level in serum.Methods:104 cases ofcoronary heart disease complicating with hyperlipemia are divided into group A and B randomly, and treated by lower dosage of Simvatatin (5mg) combining with Danshen Dropping pills and compared with conventional dosage of Sinvatatin (20mg) respectively, and measured the change of TC,TG,LDL_C,HDL_C and LP (a), AST, ALT and CK in serum before and after the treatment.Results:In both group, TC, TG and LDL_C cab be decreased and HDL_C can be increased. But in group A, the effect is more obvious. LP (a) also can be decreased and there are fewer side effects in group A. Conclusions:Lower dosage of Simvatatin combining with Danshen Dropping Pills has good effect, and fewer side effects and is more suitable for long duration treatment.
作者 胡燕 田巨龙
出处 《四川省卫生管理干部学院学报》 2004年第1期23-23,33,共2页 Journal of Sichuan Continuing Education College of Medical Sciences
关键词 辛伐他汀 丹参滴九 高脂血症 Simvatatin Danshen Dropping Pills Hyperlipemia
  • 相关文献

参考文献3

二级参考文献12

  • 1Bogdonoff Mo.Linhart J,et al.The effect of albumin infusion upon lipid mobilization in the nephrotic syndrme in man.J Clin Invest,1961;40:1024
  • 2Kaysen GA,Gambertoglio J,et al.Albumin gynthesis and hyperlipemia in nephrotci patients.Kidney Int.1987;31:1368
  • 3Lancaet.1994;344(8934):1383
  • 4Bemard DB.Extrarenal compliations of the neph rotic syndrome.kideny Int,1998;33:1184
  • 5Terje R, Pedersen TR. Lars Wilhelmsen, et al. Scandinavian Simvastatin Survival Study Group. Randomized trial of chplesterol lowering in 4 444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study(4S) [J]. Lancet, 1994,344:1383-1389
  • 6The long-term intervention with pravastatin in ischaemic chsease (LIPID)study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J] .N Engl J Ned. 1998,339:1349-1357.
  • 7Deskur-Smielecka E, Wykr Towicz A. The influence of short-term treatment with simvastatin on the inflammatory profile of patients with hyper-cholesterolemia[J] .Coronn Artery Dis,2001,12:143-148.
  • 8Santos AF, Kifel E. Safety and efficacy' of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebocontrolled stutly [J] .Transplant Proc, 200 L,B3 : 1194-1195.
  • 9Pedersen TR. Pro and con: low-density lipoprotein cholesterol lowing is and will be the key to the future of lipid management[J].Am J Cardiol,2001,8:27(5A) :8B-12B.
  • 10胡华佳,李军,成梅初.小剂量辛伐他丁治疗难治性肾病综合征高脂血症临床观察[J].湖南医学,1999,16(3):221-222. 被引量:3

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部